NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) — Brainstorm-Cell Therapeutics Inc. , ( NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative disease, today announced that it has expanded its proprietary cellular technology platform to include NurOwn®-derived exosomes for potential development across a broad range […]